Dr. Madala Ravikrishna

Dr. Ravi Krishna, an accomplished oncologist, is dedicated to working with full sincerity and discipline in a dynamic institution that offers new, interesting, and challenging cases. His commitment to advancing his knowledge and expertise is driven by a passion for providing exceptional patient care. Dr. Ravi Krishna seeks to leverage his extensive medical background to benefit patients, continuously enhancing his skills through exposure to diverse clinical scenarios. His goal is to contribute meaningfully to the field of oncology while ensuring that his patients receive the highest standard of treatment and care.

• DM Medical oncology, TATA MEMORIAL HOSPITAL
• MD (Radiation Oncology), Sri Venkateswara Institute of Medical Sciences, Tirupati (SVIMS)
• MBBS, Kurnool Medical College

• Consultant, Assistant Professor, Tata Memorial Centre, Mumbai
• Senior resident, Department of Radiation Oncology , V.I.M.S , Tirupathi
• Intern, Kurnool Medical College

Presentations and Publications:

• Patil V, Abraham G, Ravikrishna M, Bhattacharjee A, Noronha V, Parekh D, Menon N, Bajpai J, Prabhash K. Retrospective analysis: checkpoint inhibitor accessibility for thoracic and head and neck cancers and factors influencing it in a tertiary centre in India.
• Bajpai J, Panda G, Ravikrishna M, Chandrasekharan A, Rekhi B, Bhargava P, Srinivas S, Laskar S, Mokal S, Khanna N, Patil V. Vascular endothelial growth factor as a potential prognosticator in Ewing Sarcoma: a tertiary care cancer centre experience from India.
• Madala RK, Krishnatry R, Noronha V, Patil V, Joshi A, Menon N, Muthuluri H, Prabhash K. Neurological deterioration in a patient with lung cancer and brain metastasis. Cancer
• Patil VM, Noronha V, Menon N, Singh A, Ghosh-Laskar S, Budrukkar A, Bhattacharjee A, Swain M, Mathrudev V, Nawale K, Balaji A. Results of phase III randomised trial for use of docetaxel as a radiosensitizer in patients with head and neck cancer, unsuitable for cisplatin-based chemoradiation. Journal of Clinical Oncology. 2023 Jan:JCO-22.
• Prathipati A, Jilla S, Subramanian BV, Madala RK. Impact of Various Prognostic Factors on Overall Survival, Disease-Free Survival and Patterns of Failure in Carcinoma Cervix: A Tertiary Care Centre Experience from South India. Indian Journal of Gynecologic Oncology. 2018 Mar;16:1-4.
• Noronha V, Abraham G, Bondili SK, Rajpurohit A, Menon RP, Gattani S, Trikha M, Tudu R, Kota KK, Singh AK, Elamarthi P, Panda GS, Rai RK, Krishna MR, Chinthala SK, Shah MJ, Shah D, Tiwari A, Vora DN, Tongaonkar AH, John G, Patil A, Menon NS, Patil VM, Joshi A, Banavali S, Badwe RA, Prabhash K. COVID-19 vaccine uptake and vaccine hesitancy in Indian patients with cancer: A questionnaire-based survey. Cancer Res Stat Treat 2021;4:211-8.
• Mirgh SP, GokarnA, Rajendra A, More A, Kamtalwar S, Katti KS, Singh A, Goli VB, Ravind R, Madala R, Kakoti S, Maitre P, Punatar S, Chichra A, Patil A, Trivedi B,
• Joshi A, Patkar N, Tembhare P, Khanka T, Rajpal S, Chatterjee G, Kannan S, Subramanian PG, Murthy V, Shetty N, Chavan P, Bhat V, Nair S, Khattry N, Gupta S.
• Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India. Cancer Med. 2021 Dec;10(24):8777-8788.
• Patil VM, Menon N, Chatterjee A, Tonse R, Choudhari A, Mahajan A, Puranik AD, Epari S, Jadhav M, Pathak S, Peelay Z. Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial. EClinicalMedicine. 2022 July 1;49:101449.

Paper and Poster Presentations:

• Oral presentation at ASCO annual meeting 2022 in Chicago. Topic – Checkpoint inhibitor accessibility in 15,000+ Indian patients.
• Oral presentation at ASCO annual meeting 2023 in Chicago. Topic – second line palliative chemo ( OMCT vs physician choice ) in recurrent metastatic head and neck malignancies
• Oral presentation – paper on– Dosimetric comparison of deep inspiration breath-hold with active breathing coordinator versus free-breathing in carcinoma left breast patients receiving adjuvant radiotherapy” at INTERNATIONAL CANCER CONGRESS-2016, Nagpur.
• Poster presentation on Malignant acrospiroma of chest wall , in AROICON 2015 held At King George’s Medical University, Lucknow

Thesis:

• Dosimetric comparison of deep inspiration breath-hold with active breathing coordinator versus free-breathing in carcinoma left breast patients receiving adjuvant radiotherapy.
• Demographics, Pattern of care, Outcome analysis, Prognostic markers of skin and soft-tissue tumours among extremity and non-extremity sites.